Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Aug 1;80(8):833-842.
doi: 10.1001/jamaneurol.2023.1792.

Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial

Collaborators, Affiliations
Randomized Controlled Trial

Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial

Stefan Wolf et al. JAMA Neurol. .

Erratum in

  • Error in Figure 2.
    [No authors listed] [No authors listed] JAMA Neurol. 2023 Aug 1;80(8):873. doi: 10.1001/jamaneurol.2023.3002. JAMA Neurol. 2023. PMID: 37578477 Free PMC article. No abstract available.

Abstract

Importance: After aneurysmal subarachnoid hemorrhage, the use of lumbar drains has been suggested to decrease the incidence of delayed cerebral ischemia and improve long-term outcome.

Objective: To determine the effectiveness of early lumbar cerebrospinal fluid drainage added to standard of care in patients after aneurysmal subarachnoid hemorrhage.

Design, setting, and participants: The EARLYDRAIN trial was a pragmatic, multicenter, parallel-group, open-label randomized clinical trial with blinded end point evaluation conducted at 19 centers in Germany, Switzerland, and Canada. The first patient entered January 31, 2011, and the last on January 24, 2016, after 307 randomizations. Follow-up was completed July 2016. Query and retrieval of data on missing items in the case report forms was completed in September 2020. A total of 20 randomizations were invalid, the main reason being lack of informed consent. No participants meeting all inclusion and exclusion criteria were excluded from the intention-to-treat analysis. Exclusion of patients was only performed in per-protocol sensitivity analysis. A total of 287 adult patients with acute aneurysmal subarachnoid hemorrhage of all clinical grades were analyzable. Aneurysm treatment with clipping or coiling was performed within 48 hours.

Intervention: A total of 144 patients were randomized to receive an additional lumbar drain after aneurysm treatment and 143 patients to standard of care only. Early lumbar drainage with 5 mL per hour was started within 72 hours of the subarachnoid hemorrhage.

Main outcomes and measures: Primary outcome was the rate of unfavorable outcome, defined as modified Rankin Scale score of 3 to 6 (range, 0 to 6), obtained by masked assessors 6 months after hemorrhage.

Results: Of 287 included patients, 197 (68.6%) were female, and the median (IQR) age was 55 (48-63) years. Lumbar drainage started at a median (IQR) of day 2 (1-2) after aneurysmal subarachnoid hemorrhage. At 6 months, 47 patients (32.6%) in the lumbar drain group and 64 patients (44.8%) in the standard of care group had an unfavorable neurological outcome (risk ratio, 0.73; 95% CI, 0.52 to 0.98; absolute risk difference, -0.12; 95% CI, -0.23 to -0.01; P = .04). Patients treated with a lumbar drain had fewer secondary infarctions at discharge (41 patients [28.5%] vs 57 patients [39.9%]; risk ratio, 0.71; 95% CI, 0.49 to 0.99; absolute risk difference, -0.11; 95% CI, -0.22 to 0; P = .04).

Conclusion and relevance: In this trial, prophylactic lumbar drainage after aneurysmal subarachnoid hemorrhage lessened the burden of secondary infarction and decreased the rate of unfavorable outcome at 6 months. These findings support the use of lumbar drains after aneurysmal subarachnoid hemorrhage.

Trial registration: ClinicalTrials.gov Identifier: NCT01258257.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Czorlich has received personal fees from Acasti Pharma outside the submitted work. Dr Lemcke has received grants from the German Social Accident Insurance (Deutsche Gesetzliche Unfallversicherung e.V.) and B.Braun Aesculap as well as personal fees from Aesculap Academy outside the submitted work. Dr Meyer has received grants from the Technical University of Munich during the conduct of the study; grants from Zeiss; personal fees from Brainlab and Icotec; royalties from Spineart and Medacta; and owns stock in Sonovum outside the submitted work. Dr Rohde has received nonfinancial support from Zeiss and personal fees from Storz outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. CONSORT Diagram
Patients were screened by acute care clinicians from the affiliated centers, mainly the departments of neurology and neurosurgery. Numbers of screened patients were not recorded in all affiliated hospitals (eTable 2 in Supplement 2).
Figure 2.
Figure 2.. Scores on the Modified Rankin Scale (mRS) at 6 Months, Intention-to-Treat Data
Patients in the lumbar drain group received standard of care and additional lumbar drain at a planned rate of 5-mL lumbar cerebrospinal fluid diversion in the first 8 days. Patients in the standard of care group received standard of care subarachnoid hemorrhage treatment alone. Scores on the mRS range from 0 to 6, with 0 indicating no symptoms; 1, no clinically significant disability; 2, minor functional impairment; 3, moderate disability with preserved ability to walk; 4, moderate severe functional impairment without ability to walk without assistance; 5, severe functional impairment requiring constant care; and 6, death.
Figure 3.
Figure 3.. Subgroup Analysis
The forest plot shows that the relative risk of moderate-grade to high-grade functional disability or death favors treatment with a lumbar drain additional to standard of care across all prespecified subgroups. Hunt-Hess and World Federations of Neurosurgical Societies (WFNS) scales are severity gradings scales, with 1 indicating the least severe and 5 indicating the worst neurological status on admission. The modified Fisher classification is a radiological grading scale of subarachnoid hemorrhage severity ranging from 1 to 4, with higher scores indicating more severity. EVD indicates external ventricular drain; mRS, modified Rankin Scale.

Comment in

References

    1. Nieuwkamp DJ, Setz LE, Algra A, Linn FHH, de Rooij NK, Rinkel GJE. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8(7):635-642. doi:10.1016/S1474-4422(09)70126-7 - DOI - PubMed
    1. Lovelock CE, Rinkel GJE, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology. 2010;74(19):1494-1501. doi:10.1212/WNL.0b013e3181dd42b3 - DOI - PMC - PubMed
    1. Macdonald RL. Origins of the concept of vasospasm. Stroke. 2016;47(1):e11-e15. doi:10.1161/STROKEAHA.114.006498 - DOI - PubMed
    1. Macdonald RL, Higashida RT, Keller E, et al. . Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618-625. doi:10.1016/S1474-4422(11)70108-9 - DOI - PubMed
    1. Macdonald RL, Higashida RT, Keller E, et al. . Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012;43(6):1463-1469. doi:10.1161/STROKEAHA.111.648980 - DOI - PubMed

Publication types

Associated data